Insider Transactions in Q2 2015 at Thermo Fisher Scientific Inc. (TMO)
Insider Transaction List (Q2 2015)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 03
2015
|
Tyler Jacks Director |
SELL
Open market or private sale
|
Direct |
15,000
-61.17%
|
$1,935,000
$129.95 P/Share
|
Jun 03
2015
|
Tyler Jacks Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+37.95%
|
$825,000
$55.0 P/Share
|
Jun 01
2015
|
Marc N Casper Chairman & CEO |
SELL
Bona fide gift
|
Direct |
190
-0.05%
|
-
|
Jun 01
2015
|
Alan J Malus Executive Vice President |
SELL
Open market or private sale
|
Direct |
40,350
-22.01%
|
$5,205,150
$129.29 P/Share
|
Jun 01
2015
|
Alan J Malus Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
40,350
+29.77%
|
$1,452,600
$36.1 P/Share
|
May 26
2015
|
Thomas J Lynch Director |
SELL
Open market or private sale
|
Direct |
5,000
-31.06%
|
$655,000
$131.09 P/Share
|
May 26
2015
|
Thomas J Lynch Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+23.7%
|
$275,000
$55.0 P/Share
|
May 21
2015
|
Peter M Wilver Exec. VP & Chief Admin Officer |
SELL
Open market or private sale
|
Direct |
28,100
-23.35%
|
$3,737,300
$133.0 P/Share
|
May 21
2015
|
Peter M Wilver Exec. VP & Chief Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,100
+13.08%
|
$886,900
$49.49 P/Share
|
May 20
2015
|
Nelson Chai Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+11.69%
|
-
|
May 20
2015
|
C Martin Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+19.93%
|
-
|
May 20
2015
|
Tyler Jacks Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+10.67%
|
-
|
May 20
2015
|
Judy C Lewent Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+7.21%
|
-
|
May 20
2015
|
Thomas J Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+9.29%
|
-
|
May 20
2015
|
Jim P Manzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+2.64%
|
-
|
May 20
2015
|
William G Parrett Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+7.7%
|
-
|
May 20
2015
|
Lars Rebien Sorensen Director |
SELL
Payment of exercise price or tax liability
|
Direct |
394
-5.6%
|
$52,008
$132.02 P/Share
|
May 20
2015
|
Lars Rebien Sorensen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+13.9%
|
-
|
May 20
2015
|
Elaine Ullian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+10.16%
|
-
|
May 20
2015
|
Scott M Sperling Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,137
+1.7%
|
-
|
May 15
2015
|
Alan J Malus Executive Vice President |
SELL
Open market or private sale
|
Direct |
40,350
-23.09%
|
$5,245,500
$130.27 P/Share
|
May 15
2015
|
Alan J Malus Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
40,350
+29.77%
|
$1,452,600
$36.1 P/Share
|
Apr 23
2015
|
Thomas J Lynch Director |
SELL
Open market or private sale
|
Direct |
5,000
-33.42%
|
$650,000
$130.15 P/Share
|
Apr 23
2015
|
Thomas J Lynch Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+25.05%
|
$275,000
$55.0 P/Share
|
Apr 21
2015
|
Seth H Hoogasian Sr. VP & Retiring Gen. Counsel |
SELL
Open market or private sale
|
Direct |
13,256
-26.45%
|
$1,789,560
$135.0 P/Share
|
Apr 21
2015
|
Seth H Hoogasian Sr. VP & Retiring Gen. Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,138
+9.2%
|
$527,176
$52.23 P/Share
|
Apr 13
2015
|
Andrew J Thomson Senior Vice President |
SELL
Open market or private sale
|
Direct |
12,425
-17.01%
|
$1,652,525
$133.5 P/Share
|
Apr 13
2015
|
Andrew J Thomson Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
12,425
+5.45%
|
$633,675
$51.32 P/Share
|
Apr 13
2015
|
Alan J Malus Executive Vice President |
SELL
Open market or private sale
|
Direct |
11,032
-8.75%
|
$1,467,256
$133.65 P/Share
|
Apr 01
2015
|
Marc N Casper Chairman & CEO |
SELL
Open market or private sale
|
Direct |
20,000
-1.21%
|
$2,660,000
$133.13 P/Share
|